CVS HEALTH Corp financial statements, FY2007–FY2025
CVS HEALTH Corp reported revenue of $402B and net income of $1.77B for the fiscal year ended 2025-12-31, as stated in its filing with US SEC EDGAR. Listed as CVS (NYSE). Fiscal year ends 31 December.
FactReportedAnnual figures as reported, in USD, 6 measures over 20 fiscal years. Each value links to the filing it came from. Nothing is restated, annualised, converted or estimated; a period a filing did not state is shown as a gap.
Annual results by fiscal year
| Fiscal year end | Revenue | Operating income | Net income | Total assets | Total liabilities | Stockholders' equity |
|---|---|---|---|---|---|---|
| 2025-12-31 | $402B | $4.66B | $1.77B | $254B | $178B | $75.2B |
| 2024-12-31 | $373B | $8.52B | $4.61B | $253B | $177B | $75.6B |
| 2023-12-31 | $358B | $13.7B | $8.34B | $250B | $173B | $76.5B |
| 2022-12-31 | $322B | $7.95B | $4.31B | $228B | $157B | $71.5B |
| 2021-12-31 | $292B | $13.3B | $8B | $233B | $158B | $75.1B |
| 2020-12-31 | $269B | $13.9B | $7.18B | $231B | $161B | $69.4B |
| 2019-12-31 | $257B | $12B | $6.63B | $222B | $158B | $63.9B |
| 2019-01-01 | — | — | — | $217B | $158B | $58.4B |
| 2018-12-31 | $194B | $4.02B | -$594M | $196B | $138B | $58.2B |
| 2017-12-31 | $185B | $9.54B | $6.62B | $95.1B | $57.4B | $37.7B |
| 2016-12-31 | $178B | $10.4B | $5.32B | $94.5B | — | $36.8B |
| 2015-12-31 | $153B | $9.47B | $5.24B | $92.4B | — | $37.2B |
| 2014-12-31 | $139B | $8.8B | $4.64B | $74.2B | — | $38B |
| 2013-12-31 | $127B | $8.04B | — | $71.5B | — | $37.9B |
| 2012-12-31 | $123B | $7.21B | — | $66.2B | — | $37.7B |
| 2011-12-31 | $107B | $6.33B | — | $64.9B | — | — |
| 2010-12-31 | $95.8B | $6.14B | $3.43B | $62.2B | — | $37.7B |
| 2009-12-31 | $98.2B | $6.42B | $3.7B | $61.6B | — | $35.8B |
| 2008-12-31 | $87.5B | $6.05B | $3.2B | $61B | — | $34.6B |
| 2007-12-29 | $76.3B | $4.79B | $2.64B | — | — | $31.3B |
About these figures
Every number on this page is a fact with a filing behind it, retrieved from US SEC EDGAR and stored with the period it belongs to. Figures are shown as the company reported them for that period; a later restatement supersedes the earlier value rather than overwriting it. Market capitalisation is not shown anywhere on this site because no licensed price source is used; the profile shows reported public float where a filing states it.